370
Participants
Start Date
February 27, 2022
Primary Completion Date
February 1, 2026
Study Completion Date
July 31, 2026
AZM Group
AZM at 20 mg/kg will be given intravenous daily for 3 days once patients are consented and enrolled into the study.
Control Group
Saline will be given intravenous daily for 3 days once patients are consented and enrolled into the study.
RECRUITING
Children's National Hospital, Washington D.C.
RECRUITING
The University of Alabama at Birmingham, Birmingham
RECRUITING
Nationwide Children's Hospital, Columbus
RECRUITING
Rainbow Babies and Children's Hospital, Cleveland
RECRUITING
Riley Children's Health, Indianapolis
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
University of Nebraska Medical Center, Omaha
RECRUITING
Oklahoma Health Sciences, Oklahoma City
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
Yale School of Medicine, New Haven
University of Alabama at Birmingham
OTHER